LayerLogic AB Secures 470M in Pre-Seed Funding to Revolutionize Rapid Biosensing with Graphene Technology

LayerLogic AB, an innovative start-up born from Chalmers University of Technology, is thrilled to announce that it has successfully raised 470,000,000 in funding—a milestone that underscores the tremendous confidence investors have in its pioneering technology. The company’s breakthrough portable sensor, powered by graphene field effect transistors, represents a significant advancement in rapid and sensitive detection of various substances. By combining the latest discoveries in nanotechnology with cutting-edge microbiology techniques, LayerLogic AB has developed a highly precise biosensor capable of delivering reliable results within minutes. This innovative solution stems from the fruitful collaboration between two prominent research groups, led by Prof. Avgust Yurgens at the Department of Microtechnology and Nanoscience and Prof. Ivan Mijakovic at the Division of Systems and Synthetic Biology, who have together fused their expertise to transform detection technology. The recent funding will play a crucial role in accelerating product development, expanding production capabilities, and driving further research into next-generation biosensing applications. With this capital infusion, LayerLogic AB is poised to scale its operations and enhance the sensor’s functionalities, bridging the gap between academic research and commercial deployment. The new investments will also support strategic hires, advanced testing protocols, and the establishment of strong industrial partnerships, ensuring that the company remains at the forefront of innovation in the biosensor market. In an era where rapid substance detection is critical across health, environmental monitoring, and security sectors, LayerLogic AB’s breakthrough heralds a new chapter in sensor technology that promises to deliver transformative benefits across industries.